The CNBP Gene Myotonic Dystrophy Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CNBP gene, which are responsible for causing Myotonic Dystrophy Type 2 (DM2). DM2 is a form of muscular dystrophy that affects muscle function and can lead to a range of symptoms from myotonia, muscle weakness, cataracts, to heart problems. This genetic test is crucial for individuals with a family history of DM2 or those exhibiting symptoms, as it provides definitive diagnosis, allowing for appropriate management and treatment plans to be established. The test is priced at 4400 AED and involves a detailed analysis of the patient's DNA to detect the specific genetic mutation associated with the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with Myotonic Dystrophy Type 2.
The MTM1 Gene Myotubular Myopathy X-Linked Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MTM1 gene, which are responsible for causing X-linked myotubular myopathy (XLMTM). This rare, inherited disorder primarily affects skeletal muscles, leading to muscle weakness, respiratory difficulties, and in severe cases, early mortality. The condition predominantly affects males due to its X-linked inheritance pattern.
Given the critical nature of early diagnosis for managing symptoms and planning treatment strategies, this genetic test plays a vital role in identifying affected individuals. The test involves analyzing the patient's DNA to detect any abnormalities in the MTM1 gene, which provides instructions for producing myotubularin, a protein essential for muscle cell function.
The cost of the MTM1 Gene Myotubular Myopathy X-Linked Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the testing, including the sophisticated techniques used to accurately identify gene mutations and the professional expertise required to interpret the results. Undergoing this test at DNA Labs UAE ensures access to cutting-edge genetic testing technology, along with support from experienced genetic counselors who can provide valuable insights into the implications of the test results for the patient and their family.
The HCRT Gene Narcolepsy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the hypocretin (orexin) receptor 2 gene (HCRT), which are strongly associated with the development of narcolepsy. Narcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep, often leading to significant disruptions in daily life. This genetic test plays a crucial role in the early detection and diagnosis of narcolepsy, allowing for timely intervention and management of the condition.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test requires a simple blood sample from the patient. The sample is then analyzed for specific genetic markers that indicate a predisposition to narcolepsy. The process is highly accurate, leveraging advanced genetic sequencing techniques to ensure reliable results.
The cost of the HCRT Gene Narcolepsy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential for improved quality of life through personalized treatment plans make it a worthwhile investment for individuals experiencing symptoms of narcolepsy or those with a family history of the disorder.
The TPM3 Gene Nemaline Myopathy Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TPM3 gene, which are known to cause Nemaline Myopathy Type 1. This condition is a rare genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, which can affect individuals from infancy or childhood, leading to difficulties in walking, feeding, and breathing. The test involves analyzing the patient's DNA to detect any abnormalities in the TPM3 gene, providing crucial information for accurate diagnosis, management, and understanding of the disorder's progression. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology employed to ensure precise and reliable results. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures that patients receive comprehensive support throughout the testing process, from sample collection to result interpretation, aiding in the better management of Nemaline Myopathy Type 1.
The NEB Gene Nemaline Myopathy Type 2 Autosomal Recessive Genetic Test is a specialized diagnostic examination designed to detect mutations in the NEB gene, which are responsible for causing Nemaline Myopathy Type 2 (NEM2). Nemaline Myopathy is a genetic muscle disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, affecting individuals from infancy or early childhood. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
This genetic test is crucial for the accurate diagnosis of Nemaline Myopathy Type 2, enabling healthcare professionals to provide appropriate management and treatment options for affected individuals. It involves the collection of a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the NEB gene.
Performed at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test ensures high accuracy and reliability. The cost of the NEB Gene Nemaline Myopathy Type 2 Autosomal Recessive Genetic Test is 4400 AED. Opting for this test at DNA Labs UAE offers individuals and families the advantage of accessing cutting-edge genetic testing technologies, expert interpretation of results, and comprehensive support throughout the testing process.
The ACTA1 gene is crucial for encoding actin, a protein that plays a vital role in muscle contraction and structure. Mutations in the ACTA1 gene are associated with Nemaline Myopathy Type 3, a genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle fibers, visible under a microscope. This condition is part of a spectrum of neuromuscular disorders that can vary in severity and onset, often presenting challenges in movement and respiratory function.
To diagnose this specific form of myopathy, genetic testing is available at DNA Labs UAE, focusing on identifying mutations within the ACTA1 gene. The test is an essential tool for confirming the diagnosis, understanding the disease's progression, and assisting in managing and planning treatment options. It involves analyzing the patient's DNA to pinpoint mutations in the ACTA1 gene that are known to cause Nemaline Myopathy Type 3.
The cost of the ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to accurately identify the genetic alterations responsible for the condition. Given the complexity of genetic testing and the expertise required, the cost reflects the resources and technology utilized to provide a definitive diagnosis. This test is a critical step for affected individuals and their families to gain a clear understanding of the condition and to navigate the challenges associated with Nemaline Myopathy Type 3.
The TPM2 Gene Nemaline Myopathy Type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the TPM2 gene, which are associated with Nemaline Myopathy Type 4. Nemaline Myopathy is a genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures called nemaline bodies in muscle fibers, visible under a microscope. The condition is part of a broader group of neuromuscular disorders that can vary in severity and onset, with some forms present from birth.
The TPM2 gene plays a crucial role in muscle function and structure, encoding a protein essential for muscle fiber stability and contraction. Mutations in this gene can disrupt normal muscle function, leading to the symptoms observed in Nemaline Myopathy Type 4.
The genetic test at DNA Labs UAE involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the TPM2 gene. This test is vital for confirming the diagnosis of Nemaline Myopathy Type 4, allowing for a better understanding of the condition's prognosis, and informing treatment and management decisions. It is also useful for genetic counseling, helping families understand the risk of the disorder being passed on to future generations.
The cost of the TPM2 Gene Nemaline Myopathy Type 4 Genetic Test at DNA Labs UAE is 3200 AED. The test is conducted in a state-of-the-art laboratory by experienced geneticists and technicians, ensuring accurate and reliable results.
The TNNT1 Gene Nemaline Myopathy Type 5 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TNNT1 gene, which are responsible for Nemaline Myopathy Type 5. This condition is a rare genetic disorder characterized by muscle weakness, hypotonia, and the presence of rod-like structures called nemaline bodies in muscle fibers, discernible under a microscope. The TNNT1 gene plays a crucial role in the development and function of skeletal muscles, and mutations in this gene can lead to the symptoms associated with Nemaline Myopathy Type 5.
This genetic test involves analyzing the patient's DNA to detect mutations in the TNNT1 gene, offering crucial information for the diagnosis, management, and understanding of the genetic risk for family members. The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate, reliable, and comprehensive diagnostic services. By opting for this test, individuals suspected of having Nemaline Myopathy Type 5 or their family members can gain valuable insights into their condition, facilitating informed decisions regarding treatment and genetic counseling.
The KBTBD13 Gene Nemaline Myopathy Type 6 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KBTBD13 gene, which are responsible for causing Nemaline Myopathy Type 6. This rare genetic disorder is characterized by muscle weakness, hypotonia, and the presence of rod-like structures in muscle cells, known as nemaline bodies. Early diagnosis through this genetic test is crucial for managing symptoms and improving the quality of life for affected individuals. The test is priced at 4400 AED and is conducted in the advanced facilities of DNA Labs UAE, ensuring accurate and reliable results. By analyzing a small sample of the patient's DNA, this test provides valuable information for genetic counseling and guides decision-making regarding treatment options.
The CFL2 gene nemaline myopathy type 7 genetic test is a specialized diagnostic tool designed to identify mutations in the CFL2 gene, which are associated with nemaline myopathy type 7. This condition is a rare genetic disorder characterized by muscle weakness, hypotonia, and the presence of nemaline bodies in muscle fibers. Early detection through genetic testing can be crucial for management and treatment planning.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability of results. The cost of the test is 4400 AED, an investment in obtaining crucial genetic information that can guide patient care and inform family planning decisions. This test is essential for families with a history of nemaline myopathy or individuals showing symptoms related to the disorder, providing them with a clear genetic understanding of their condition.
